Letters by company

WuXi Biologics

1 letter discussing WXIBF. Everything written about it on this site is on its ticker page.

Chautauqua Capital Management Q2 2026 International & Global Funds Market Commentary Chautauqua trimmed semiconductor and automation winners, added to Adyen and Constellation Software, and built 3i and AIA as valuations in lagging holdings compressed despite continued earnings growth. It pairs TSMC, ASML, Keyence and Fanuc with software, China and health-care franchises, arguing that durable cash generation and competitive moats can close the gap between intrinsic value and prices. Q2 2026 453950 ADYEY $31BASML $662B